Axsome Therapeutics Inc (AXSM)
R&D Expense Growth
-12.24%
Quarterly · Period ending:
AXSM R&D Expense Growth
Latest reported-12.24%period ending
Latest reported-12.24%period ending
AXSM Quarterly R&D Growth (QoQ) (0.00% → -12.24%)
Latest values, visible window
High-resolution chart · PNG
AXSM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -12.2444% | |
| 7.9646% | |
| 21.4855% | |
| -18.9318% | |
| 10.6196% | |
| -18.5816% | |
| 21.1906% | |
| -8.9563% | |
| 35.3598% | |
| 19.5663% | |
| 7.0776% | |
| 39.7745% | |
| 15.6691% | |
| 21.0978% | |
| -1.2363% | |
| -5.7941% | |
| 25.4827% | |
| -8.6816% | |
| 4.5613% | |
| -9.1225% | |
| -12.6079% | |
| -4.5387% | |
| 17.5002% | |
| 40.3353% | |
| -61.6918% | |
| 43.3013% | |
| 21.2793% | |
| 43.9186% | |
| 44.7195% | |
| 6.3185% | |
| 18.3826% | |
| 8.8325% | |
| 16.7916% | |
| 5.7545% | |
| 0.5096% | |
| -10.7089% | |
| -16.3379% | |
| 3.0731% | |
| 4.2737% | |
| 5.1097% | |
| 17.0518% | |
| 105.0012% | |
| 44.8388% | |
| -6.3866% | |
| 14.9766% | |
| 5.1024% | |
| 3.5345% | |
| 59.6817% | |
| -0.0001% | |
| 0% |